Xiaobin Wu - 11 Jun 2026 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Reporting relationship: President and COO
Issuer ticker: ONC
Reported as of: 11 Jun 2026
Net transaction value: -$163,512
SEC form: 4
Accepted by SEC: 15 Jun 2026, 17:55:18 UTC
Prior SEC filing: 10 Jun 2026
Next SEC filing: 18 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Qing Nian, as Attorney-in-Fact

Key filing fact

Xiaobin Wu filed Form 4 for BeOne Medicines Ltd. (ONC) on 15 Jun 2026.

Key facts

This page summarizes Xiaobin Wu's Form 4 filing for BeOne Medicines Ltd. (ONC).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 15 Jun 2026, 17:55.

Change

Previous filing in this sequence was filed on 10 Jun 2026.
Current net transaction value: -$163,512.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001739452 Primary reporting owner

Wu Xiaobin

Relationship: President and COO
Address: C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND
Signature: /s/ Qing Nian, as Attorney-in-Fact
Signature date: 15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONC transaction

Ordinary Shares

Award

Transaction value
Shares: +118,625
Change %: +10%
Price: $0.000000^*
Shares after: 1,308,161
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F1

ONC transaction

American Depositary Shares

Sale

Transaction value: $163,512
Shares: -626
Change %: -100%
Price: $261.20
Shares after: 0
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F2, F3, F4

ONC holding

American Depositary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 12,365
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F2

ONC holding

American Depositary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,000
Date: 11 Jun 2026
Ownership: By Wife
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ONC transaction Derivative

Share Option (Right to Buy)

Award

Transaction value
Shares: +229,775
Change %
Price: $0.000000^*
Shares after: 229,775
Date: 11 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 229,775
Exercise price: $20.81
Footnotes: F5, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Footnote F2

Each American Depositary Share represents 13 Ordinary Shares.

Footnote F3

The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.19 to $261.29, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Footnote F5

The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.

Footnote F6

These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.